Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(60%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(1)
Other(1)

Detailed Status

Recruiting2
Completed1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed120%
recruiting240%
unknown120%
active_not_recruiting120%

Recent Activity

3 active trials
Showing 5 of 5
recruitingnot_applicable

Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC

NCT05122806
recruiting

Advanced Translational Research on Childhood Leukemia

NCT04478006
active_not_recruiting

The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination

NCT06751251
unknown

Deciphering the Role of Circular RNAs in ALKpositive Anaplastic Large-cell Lymphoma

NCT05934045
completed

Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers

NCT03383211

Clinical Trials (5)

Showing 5 of 5 trials
NCT05122806Not Applicable

Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC

Recruiting
NCT04478006

Advanced Translational Research on Childhood Leukemia

Recruiting
NCT06751251

The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination

Active Not Recruiting
NCT05934045

Deciphering the Role of Circular RNAs in ALKpositive Anaplastic Large-cell Lymphoma

Unknown
NCT03383211

Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers

Completed

All 5 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
5